SCHEMBL22325211

SCHEMBL22325211

CC1(CO)CCC(c2ccc(Cl)cc2)=C(CCl)C1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
BCL2L1 Q07817 1/20 0.40
PTGS2 P35354 5/20 0.36
PTGS1 P23219 4/20 0.36
BCL2 P10415 3/20 0.36
SLC6A3 Q01959 3/20 0.33
SLC6A2 P23975 1/20 0.32
ACHE P22303 1/20 0.31
PDE7A Q13946 1/20 0.31
PTGES O14684 1/20 0.30
ALOX5 P09917 1/20 0.30
ALOX5AP P20292 1/20 0.30
LMNA P02545 1/20 0.30
MAPK1 P28482 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26648644 1.00 BCL2L1 (0.40) BCL2L1PTGS2PTGS1BCL2SLC6A3
SCHEMBL33529723 0.91 BCL2L1 (0.40) BCL2L1PTGS2PTGS1BCL2SLC6A3
SCHEMBL22325185 0.91 BCL2L1 (0.40) BCL2L1PTGS2PTGS1BCL2SLC6A3
SCHEMBL25215204 0.81 BCL2L1 (0.51) BCL2L1PTGS2PTGS1BCL2SLC6A3
SCHEMBL25254777 0.76 PTGS2 (0.43) BCL2L1PTGS2PTGS1BCL2SLC6A3
SCHEMBL1113744 0.76 BCL2L1 (0.52) BCL2L1PTGS2PTGS1BCL2SLC6A3
SCHEMBL30834678 0.74 SLC6A3 (0.43) SLC6A3SLC6A2LMNAMAPK1NPSR1
SCHEMBL1959392 0.74 PTGS2 (0.45) BCL2L1PTGS2PTGS1BCL2SLC6A3
SCHEMBL25244236 0.73 PTGS2 (0.42) BCL2L1PTGS2PTGS1SLC6A3SLC6A2
SCHEMBL5394022 0.72 SMN1; SMN2 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023220425-A1 BCL-XL/BCL-2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-11-16 WO disclosed
EP-3920923-A2 THERAPEUTIC AGENTS AND METHODS OF TREATMENT University of Florida Research Foundation, Incorporated (US) 2021-12-15 EP disclosed
WO-2020163823-A2 THERAPEUTIC AGENTS AND METHODS OF TREATMENT UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2020-08-13 WO disclosed